Notice to stakeholders: Development and release of non-prescription drug Cough, Cold and Flu labelling standard

April 2024

In advance of a regulatory proposal amending the Food and Drug Regulations to simplify market access for non-prescription drug products, Health Canada has developed a Non-prescription Drug (NPD) Action Plan. This Action Plan advances the concepts of the Self-Care Framework to reduce burden where possible and to align the level of oversight of NPDs based on their level of risk. This Action Plan introduces policy and operational- based solutions to remove barriers for getting NPDs (excluding ethical drugs, controlled substances, and biocides) to market.

Through this notice, Health Canada is informing stakeholders that it is working to finalize a Cough, Cold and Flu Labelling Standard (CCF LS), which will capture single and multi-ingredient orally administered non-prescription products for use in adults (12 years and older) to provide relief of symptoms associated with the common cold.

Health Canada released a draft CCF LS for consultation in summer 2024, and targets finalization in late fall 2024.

Information Resources

Nil

Contact Information

Questions can be sent to:
E-Mail: nnhpd-dpsnso@hc-sc.gc.ca